Protara Therapeutics, Inc. Income (Loss) from Continuing Operations, Per Diluted Share
Protara Therapeutics, Inc. (TARA) reported Income (Loss) from Continuing Operations, Per Diluted Share of $0.48 per share for the 3-month period ending 2014-12-31, per its 10-K filed 2016-03-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare · last filed 2016-03-14
- Protara Therapeutics, Inc. income (loss) from continuing operations, per diluted share for the quarter ending 2014-12-31 was $0.48.
- Protara Therapeutics, Inc. income (loss) from continuing operations, per diluted share for the quarter ending 2014-09-30 was -$31.00.
- Protara Therapeutics, Inc. income (loss) from continuing operations, per diluted share for the quarter ending 2014-06-30 was -$18.55.
- Protara Therapeutics, Inc. income (loss) from continuing operations, per diluted share for the quarter ending 2014-03-31 was -$18.09.
| Period end | Income (Loss) from Continuing Operations, Per Diluted Share 3 month |
|---|---|
| 2014-12-31 | $0.48 10-K · filed 2016-03-14 |
| 2014-09-30 | -$31.00 10-K · filed 2016-03-14 |
| 2014-06-30 | -$18.55 10-K · filed 2016-03-14 |
| 2014-03-31 | -$18.09 10-K · filed 2016-03-14 |
| 2013-12-31 | -$16.41 10-K · filed 2015-03-20 |
| 2013-09-30 | -$15.21 10-K · filed 2015-03-20 |
| 2013-06-30 | -$13.33 10-K · filed 2015-03-20 |
| 2013-03-31 | -$14.64 10-K · filed 2015-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |